Lentiviral expression of CTLA4Ig inhibits primed xenogeneic lymphocyte proliferation and cytokine responses

Xenotransplantation

Volumn 13, Issue 3, 2006, Pages 248-252

  Mulley, William R ^a   Wee, Janet L ^a   Christiansen, Dale ^a   Milland, Julie ^a   Ierino, Francesco L ^a,b   Sandrin, Mauro S ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

CTLA4Ig; Lentivirus; Primed T cells; Xenotransplantation

Indexed keywords

ABATACEPT; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; CYTOKINES; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; IMMUNOCONJUGATES; LENTIVIRUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; SPLEEN; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 33744756305     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2006.00297.x     Document Type: Article

References (23)

1. Salomon B Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Ann Rev Immunol 2001 19 : 225.
2. Gimmi CD Freeman GJ Gribben JG Gray G Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A 1993 90 : 6586.
3. Lenschow DJ Zeng Y Thistlethwaite Jr et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992 257 : 789.
4. Baliga P Chavin KD Qin L et al. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 1994 58 : 1082.
5. Gause WC Mitro V Via C et al. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J Immunol 1997 159 : 1055.
6. London CA Lodge MP Abbas AK. Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000 164 : 265.
7. Fu F Li W Lu L et al. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc 1999 31 : 1244.
8. Kimura F Gotoh M Tanaka T et al. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion. Diabetologia 2002 45 : 831.
9. Gainer AL Korbutt GS Rajotte RV Warnock GL Elliott JF. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 1997 63 : 1017.
10. Feng S Quickel RR Hollister-Lock J et al. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation 1999 67 : 1607.
11. Olthoff KM Judge TA Gelman AE et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med 1998 4 : 194.
12. Steurer W Nickerson PW Steele AW et al. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995 155 : 1165.
13. Yun S Gustafsson K Fabre JW. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Transplantation 1998 66 : 103.
14. Plebanski M Gilbert SC Schneider J et al. Protection from plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Eur J Immunol 1998 28 : 4345.
15. Blomer U Naldini L Kafri T et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997 71 : 6641.
16. Naldini L Blomer U Gage FH Trono D Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996 93 : 11382.
17. Yang Y Nunes FA Berencsi K et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994 91 : 4407.
18. Yamada A Chandraker A Laufer TM et al. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol 2001 167 : 5522.
19. Auchincloss H Sachs DH Jr.. Xenogeneic transplantation. Ann Rev Immunol 1998 16 : 433.
20. Linsley PS Wallace PM Johnson J et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992 257 : 792.
21. Mellor AL Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004 4 : 762.
22. Boasso A Herbeuval JP Hardy AW Winkler C Shearer GM. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 2005 105 : 1574.
23. Terness P Chuang JJ Bauer T Jiga L Opelz G. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cell: too much ado about IDO? Blood 2005 105 : 2480.